St. Jude Riata Lead Lawsuit

Background information on St. Jude Riata Lead lawsuits and litigation updates published between 2011 to 2014.

St. Jude Riata Lead Lawsuit Overview

The St. Jude Riata litigation involved claims that defective cardiac defibrillator leads manufactured by St. Jude Medical caused serious health complications and deaths among patients implanted with the devices.

The Riata and Riata ST leads, designed to deliver life-saving electrical shocks to regulate heart rhythm, were later found to suffer from insulation failures that allowed the internal conductor wires to break through their protective coating. This defect led to abnormal shocks, failure to deliver therapy when needed, and difficulties during device removal, creating life-threatening situations for patients.

As reports of lead failures increased, the U.S. Food and Drug Administration announced a Class I recall in 2011, identifying the issue as a risk of injury or death. Lawsuits soon followed, accusing St. Jude of manufacturing and selling a defective medical device and failing to warn physicians and patients about known insulation problems. Plaintiffs alleged that the company continued to market the Riata leads despite evidence of early wear and abrasion, prioritizing profits over patient safety.

Hundreds of product liability lawsuits were filed nationwide, many of which were centralized for coordinated proceedings. While St. Jude denied wrongdoing, the litigation led to settlements compensating patients who suffered injuries or required risky lead extractions.

St. Jude Riata Lead Litigation Updates

April 22, 2015: St. Jude Riata Defibrillator Lead Lawsuits Settled

St. Jude Medical reached a settlement to resolve a group of lawsuits filed over its recalled Riata and Riata ST defibrillator leads. The agreement came after years of litigation claiming the defective heart wires could erode through their insulation, creating life-threatening risks of electrical failure and cardiac injury.

June 30, 2014: Federal Court Upholds Preemption Defense in St. Jude Riata Lead Lawsuits

A federal judge dismissed several product liability lawsuits filed over St. Jude’s Riata defibrillator leads, ruling that federal preemption barred most state-law claims. The decision limited legal avenues for plaintiffs but allowed certain negligence allegations related to post-market conduct to proceed.

October 9, 2013: Bellwether Schedule Established in St. Jude Riata Lead Litigation

The U.S. District Court overseeing the consolidated Riata lead litigation set a bellwether trial schedule to test key legal and scientific issues before juries. The cases selected were meant to represent common claims about insulation failure, internal wire exposure, and the need for risky lead extraction surgeries.

November 18, 2012: Federal Judge Rejects Motion to Dismiss St. Jude Riata Lawsuits on Preemption Grounds

A federal court denied St. Jude Medical’s motion to dismiss lawsuits over its Riata and Riata ST leads, allowing plaintiffs to move forward with claims that the manufacturer failed to warn doctors and regulators about known insulation problems before the devices were recalled.

St. Jude Riata Research and Reports

July 1, 2014: St. Jude Factory Problems Reportedly Fixed Following Riata and Durata Concerns

St. Jude Medical announced that it had resolved manufacturing issues at its Sylmar, California plant, which produced the recalled Riata and Durata defibrillator leads. The company said the improvements addressed prior FDA inspection findings that cited quality control and documentation failures.

January 9, 2013: Durata Lead Case Report Highlights Continued Failure Risks

A published case study described a patient experiencing insulation damage with a St. Jude Durata lead, echoing concerns raised by the earlier Riata recalls. Researchers warned that Durata’s supposedly improved coating might not fully eliminate the risk of internal wire exposure.

October 3, 2012: Studies Find Riata Lead Failure Rates Higher Than St. Jude Estimated

New independent studies found that failure rates for St. Jude Riata defibrillator leads were significantly higher than the manufacturer had reported. Researchers emphasized that exposed wires and insulation breakdowns could cause inappropriate shocks or device failure during cardiac events.

August 13, 2012: FDA Restricts St. Jude Approvals After Recurring Lead Safety Problems

The FDA limited new product approvals for St. Jude Medical until the company addressed ongoing safety and quality assurance concerns linked to its Riata and Durata defibrillator leads. Regulators cited inadequate responses to inspection findings and required detailed corrective action plans.

July 19, 2012: St. Jude Promises Improvements Following Defibrillator Lead Failures

St. Jude pledged to strengthen its quality control and testing procedures after mounting criticism over the Riata and Durata defibrillator leads. The company said it would implement stricter monitoring and transparency measures for both existing devices and future products.

June 4, 2012: Manufacturing Concerns Persist Over St. Jude Defibrillator Leads

An FDA inspection of St. Jude’s manufacturing facilities revealed multiple violations, including poor documentation of defects and failure to maintain proper production oversight. The report reignited questions about the company’s quality control during the production of recalled heart leads.

May 16, 2012: Study Links Durata Lead Failures to Same Design Flaws Seen in Riata Models

Researchers identified mechanical stress and insulation abrasion as recurring failure mechanisms in St. Jude’s Durata leads, similar to the earlier Riata design. The findings undermined the company’s claims that Durata had resolved the safety issues that led to prior recalls.

March 23, 2012: Report Indicates St. Jude Knew About Riata Problems Before Recall

Internal documents suggested St. Jude Medical was aware of Riata lead abrasion and failure risks years before initiating a formal recall. Critics said the delay in disclosure exposed thousands of patients to unnecessary cardiac danger.

February 9, 2012: Riata Lead Replacement Costs Create New Burdens for Patients and Hospitals

As failures mounted, hospitals reported rising costs to replace recalled Riata defibrillator leads. Many patients faced the choice between risky surgical extraction or lifelong monitoring, with insurers often disputing coverage for the procedures.

January 25, 2012: FDA Warns Doctors to Closely Monitor Patients With Riata Leads

The FDA issued a safety communication urging close monitoring of patients implanted with Riata defibrillator leads after growing reports of insulation abrasion and exposed conductive wires. The agency stopped short of recommending widespread removal, citing surgical risks.

January 11, 2012: Larger Diameter St. Jude Riata Leads Linked to Higher Failure Rates

Data from field reports revealed that Riata leads with larger diameters were more prone to insulation breaches and internal wire exposure. Investigators called for design reevaluation to prevent recurring mechanical stress on the cables.

December 30, 2011: St. Jude Durata Lead Failures Reported, Despite Differences From Riata Design

Reports surfaced of Durata defibrillator leads experiencing insulation problems, despite the model being marketed as an improved alternative to the recalled Riata line. Cardiologists warned that the design may still suffer from similar structural weaknesses.

December 22, 2011: St. Jude Durata Defibrillator Leads Show Problems Similar to Riata

Physicians began documenting performance issues in St. Jude’s Durata leads, including insulation abrasion and conductor exposure. The findings fueled debate about whether the company’s newer product truly corrected the Riata defects.

February 3, 2012: Study Finds St. Jude Riata Lead Failure Rate Higher Than Expected

A new study in Heart Rhythm Journal revealed that St. Jude’s Riata defibrillator leads were failing at rates far exceeding company projections. The research intensified calls for stricter post-market surveillance of cardiac implantable devices.

January 6, 2012: St. Jude Disputes Reports Linking Riata Leads to Patient Deaths

Following growing media coverage, St. Jude Medical publicly disputed claims that its Riata defibrillator leads were responsible for patient fatalities. The company maintained that insulation failures did not necessarily translate to fatal outcomes, drawing criticism from cardiology experts.

December 29, 2011: St. Jude Identifies Problems With QuickSite and QuickFlex CRT Leads

Reports surfaced that St. Jude’s QuickSite and QuickFlex cardiac resynchronization therapy (CRT) leads suffered from insulation defects similar to those in Riata models. The company said it was evaluating corrective actions but did not issue an immediate recall.

December 22, 2011: FDA Warns of Serious Risks Linked to Recalled St. Jude Defibrillator Leads

The FDA warned that St. Jude’s Riata leads posed serious safety risks, including potential for abnormal shocks and lead failure. The agency urged doctors to use imaging to identify exposed conductors in patients with the devices implanted.

December 15, 2011: FDA Oversight Problems Highlighted in Riata Recall Response

Critics faulted the FDA for inadequate oversight in monitoring defibrillator lead safety before St. Jude’s recall of Riata devices. Reports suggested regulators missed early warning signs of widespread lead deterioration.

December 6, 2011: St. Jude Riata Defibrillator Leads Recalled Over Insulation Failures

St. Jude Medical announced a recall of its Riata and Riata ST defibrillator leads after discovering insulation erosion that could expose internal wires and lead to electrical malfunctions. The recall affected tens of thousands of implanted devices worldwide.

St. Jude Riata Lawsuit Examples

March 5, 2013: St. Jude Riata Defibrillator Lead Lawsuit Filed Over Device Failure

A new lawsuit was filed alleging that a recalled St. Jude Riata defibrillator lead failed during use, causing serious cardiac complications. The plaintiff claimed the exposed internal wires short-circuited the device, forcing emergency replacement surgery and long-term health issues.

October 17, 2012: Class Action Filed Over Recalled St. Jude Riata Defibrillator Leads

A class action lawsuit was filed on behalf of patients implanted with St. Jude Riata and Riata ST defibrillator leads, accusing the company of selling defective medical devices. The lawsuit alleged that St. Jude knew about insulation problems for years but failed to warn doctors and the public.

July 13, 2012: Lawsuits Filed Nationwide Over Recalled St. Jude Defibrillator Wires

Multiple product liability claims were filed after St. Jude’s Riata defibrillator leads were recalled due to insulation failure. Plaintiffs alleged that the defective wires caused electrical malfunctions, unnecessary shocks, and increased risk of death for patients relying on the devices.

May 7, 2012: Wrongful Death Lawsuit Filed Over St. Jude Riata Lead Malfunction

A wrongful death complaint accused St. Jude Medical of manufacturing a dangerous and defective defibrillator lead that malfunctioned and failed to deliver a life-saving shock. The lawsuit claimed the company ignored warning signs of product deterioration before the recall.

February 28, 2012: Class Action Lawsuit Filed Over St. Jude Riata Defibrillator Lead Problems

Patients implanted with Riata leads filed a class action lawsuit seeking compensation for ongoing monitoring and potential surgical removal of the recalled devices. The filing alleged that St. Jude delayed notifying the medical community despite clear evidence of insulation erosion.

February 9, 2012: Lawsuit Filed Over Failed Riata Defibrillator Lead

A patient filed an individual lawsuit after their implanted St. Jude Riata lead failed to perform correctly, requiring revision surgery. The case accused the company of negligence and misrepresentation about the safety and longevity of the device.

January 24, 2012: Riata Recall Lawsuit Filed Following Device Malfunction

A lawsuit was filed against St. Jude Medical by a patient who suffered cardiac complications linked to a recalled Riata defibrillator lead. The plaintiff alleged that the manufacturer distributed a defective product and failed to properly notify patients of the risks.

January 10, 2012: St. Jude Sued Over Failed Riata Defibrillator Lead

An early Riata-related lawsuit alleged that a defective St. Jude defibrillator wire eroded through its insulation, causing electrical failure and physical injury. The complaint contended that the company failed to perform adequate testing or issue timely warnings.

December 21, 2011: Class Action Lawsuit Filed Over St. Jude Defibrillator Lead Recall

Following the FDA’s Class I recall, a class action lawsuit was filed accusing St. Jude Medical of concealing defects in its Riata defibrillator leads. Plaintiffs sought medical monitoring, financial compensation, and punitive damages for what they described as reckless corporate conduct.